RecallRadar

FDA Drug recall D-0587-2025

Carvedilol Tablets, USP, 12.5 mg, 500 Tablets per carton, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Plot No. 2, Phase-2, Pha…

On 2025-08-20 the FDA classified a Class II recall of Carvedilol Tablets, USP, 12.5 mg, 500 Tablets per carton, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Plot No. 2, Phase-2, Pha… by Glenmark Pharmaceuticals Usa, citing CGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0587-2025
ClassificationClass II
Statusongoing
Initiated2025-08-06
Published2025-08-20
Last updated2026-09-13 11:52 UTC
CompanyGlenmark Pharmaceuticals Usa
DistributionUS

Product

Carvedilol Tablets, USP, 12.5 mg, 500 Tablets per carton, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Plot No. 2, Phase-2, Pharma Zone SEZ, Pithampur, Dist.-Dhar, Madhya Pradesh 454 775, India. Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 47430, NDC 68462-164-05

Reason

CGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm

Identifiers

ndc68462-162-60
ndc68462-162-01
ndc68462-162-18
ndc68462-162-05
ndc68462-162-10
ndc68462-163-60
ndc68462-163-01
ndc68462-163-18
ndc68462-163-05
ndc68462-163-10
ndc68462-164-60
ndc68462-164-01
ndc68462-164-18
ndc68462-164-05
ndc68462-164-10
ndc68462-165-60
ndc68462-165-01
ndc68462-165-18
ndc68462-165-05
ndc68462-165-10
code_infoLot #: 17241257, 17241258, 17241279, Exp. Date 06/2026

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0587-2025%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.